NCT00253552: G-CSF-Treated Donor Bone Marrow Transplant in Treating Patients With Hematologic Disorders |
|
|
| Terminated | N/A | 4 | US | filgrastim, busulfan, cyclophosphamide, cyclosporine, etoposide, methotrexate, allogeneic bone marrow transplantation, radiation therapy | OHSU Knight Cancer Institute, National Cancer Institute (NCI) | Chronic Myeloproliferative Disorders, Graft Versus Host Disease, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Diseases, Sarcoma | 05/06 | 05/06 | | |
